SUNDAY, JUNE 25, 2017

New data released about Chagas disease

The World Health Organization (WHO) recently released the latest data concerning the spread of Chagas disease in countries within Latin America. Experts looked at data concerning people living with Chagas disease, also known as American trypanosomiasis, which is caused by Trypanosoma cruzi. Read More »

CDC advisory panel recommends HPV vaccine

The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recently announced that it recommends people receive Gardasil®9, Merck’s 9-valent HPV vaccine. The recommendations call for females between the ages of 9 and 26 and males between the ages of 9 and 21 to receive the vaccine. Due to these recommendations, GARDASIL 9 is part of the routine vaccine recommendations for females and males ages 11 and 12. Read More »

Washington DC hosting community-based hepatitis C study

The National Institutes of Health and District of Columbia begin clinical trial of a new antiviral therapy. Read More »

Disease advancements focus of Delaware conference

New Technologies, New Vaccines will be held from March 22-25. Read More »

Themis Bioscience publishes chikungunya vaccine study results

Themis Bioscence GmbH (a biotechnology company that produces vaccines for tropical diseases) and the Institut Pasteur (a Paris-based biomedical research center) recently published the results of their phase 1 trial of their chikungunya vaccine. The double-blind, randomized, placebo-controlled, first-in-man, active-comparator study tested the safety, immunogenicity, and tolerability of the vaccine. Read More »

Soug named new CFO of Targovax

According to a recent announcement from Targovax, the company has hired Oystein Soug as the company’s new CFO. Mr. Soug will begin his new duties on June 1, 2015. Mr. Soug’s experience includes 17 years in corporate development and international finance. Mr. Soug earned his MSc in Economics and Finance as well as a Master of International Management (CEMS) from Switzerland’s University of St. Gallen. Mr. Soug previously worked in the banking industry for five years. Read More »

Website aims to clear up flu-Ebola symptom confusion

U.S. health professionals recently launched a website that uses a new educational strategy to clarify the confusion surrounding the differences between Ebola symptoms and influenza symptoms. The educational program, titled “Why Care About Seasonal Influenza in the Age of Ebola?” is a page on Paradigm Medical Communications' website in a project the company launched with Global Education Group. Read More »

Researchers find key to tuberculosis resistance

Bacterial molecule dictates body's response to TB. Read More »

Missouri taking measures to stop avian influenza

2 turkey growing facilities test positive for virus Read More »

Immunomic Therapeutics to present at BIO-Europe

Immunomic Therapeutics, a biotechnology company that is privately held and develops vaccines using its unique LAMP technology, recently announced that it will be a presenter at the BIO-Europe Spring Conference. Read More »

HPV cancer vaccine finishes successful trial

ORYX, a company that produces translational medicines -- including cancer vaccines and oncolytic virotherapy --  said on Monday that its researchers successfully have completed their Phase I/IIa trial to test a vaccine for cancers associated with the Human Papilloma Virus (HPV). Read More »

Disovery can detect and destroy noroviruses

Noroviruses are highly contagious and very unpleasant: though the illnesses are not typically fatal, patients suffer from symptoms like diarrhea and vomiting. Read More »

USDA disputes ban on poultry imports

Some countries refusing all U.S. poultry after avian influenza found. Read More »

Too early to tell if experimental Ebola vaccine safe

U.S. physician received VSVAG-ZEBOV after accidental needle stick Read More »

4 University of Oregon students contact Type B meningitis

Students encouraged to receive vaccine after 1 dies. Read More »

Kineta to present new anti-viral, vaccine research at international conferences

Small molecular program and vaccine adjuvant program to be discussed. Read More »

Blood type O defends against severe malaria

A team of Scandinavian scientists recently discovered how blood type O protects people with severe malaria from dying . Read More »

Experts encourage vaccination to protect against measles

Health professionals and experts remind the general public that vaccinations are the only way to prevent outbreaks of measles in the future. Read More »

Bill encouraging flu vaccine for elderly passes House

Legislation now in the hands of New Jersey Senate. Read More »

Phase II study of Diamyd begins

Diamond Medical hoping vaccine will prevent or delay type 1 diabetes in children. Read More »